Change in bone mineral density during adjuvant chemotherapy for early-stage breast cancer

PURPOSE: Adjuvant chemotherapy has been associated with loss of bone mineral density (BMD) either as a direct effect or due to glucocorticoids used as supportive care medication. A prospective cohort study was conducted to evaluate changes in BMD from baseline to right after completion of chemothera...

Descripción completa

Detalles Bibliográficos
Autores principales: Christensen, Carina Ørts, Cronin-Fenton, Deirdre, Frøslev, Trine, Hermann, Anne Pernille, Ewertz, Marianne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4993804/
https://www.ncbi.nlm.nih.gov/pubmed/27146497
http://dx.doi.org/10.1007/s00520-016-3250-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4993804/
https://www.ncbi.nlm.nih.gov/pubmed/27146497
http://dx.doi.org/10.1007/s00520-016-3250-y

Ejemplares similares